Pierpaolo Cavallo

Dr. Pierpaolo Cavallo

University of Salerno, Department of Physics
+1
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2016 in BMC Research Notes
Verified
Journal Article
Open access
PDF file
Pierpaolo CavalloPierpaolo Cavallo
Pierpaolo Cavallo
LCLuna Carpinelli
Luna Carpinelli
Giulia SavareseGiulia Savarese
Giulia Savarese
Many studies have shown the correlation between bruxism and stress that affects the quality of life of university students. The present study highlights this correlation—for the first time—in a group of university students in Italy. We have investigated the prevalence of awake and asleep bruxism and its correlation with perceived stress in a group of 278 Italian undergraduate students (117 M). A self report questionnaire was constructed using a socio-demographic test, the Perceived Stress Scale (PSS) and the item n. 8 of the Fonseca Questionnaire for presence of bruxism. The perceived stress score using PSS-10 scale was 32.2 (SD 4.6, 95% CL 31.6–32.7) for all the subjects, with significant gender difference: M = 31.2 and F = 32.9 (P = 0.0019). The prevalence for awake bruxism was 37.9% (F = 40.8%; M = 34.2%,), while for sleep bruxism was 31.8% (F = 33.3%; M = 29.1%), both without significant gender difference. A positive correlation, with significant concordance and dependence, between stress score and awake bruxism was present for male students only. University students showed higher bruxism and stress levels compared to the general population, with higher stress for females, but, even if female students show higher stress, a correlation between stress and bruxism exists only for male gender. Further studies should be performed.

8 July 2014 in Molecules
Verified
Journal Article
Open access
PDF file
Francesco VinaleFrancesco Vinale
Francesco Vinale
GMGelsomina Manganiello
Gelsomina Manganiello
MNMarco Nigro
Marco Nigro
PMPierluigi Mazzei
Pierluigi Mazzei
APAlessandro Piccolo
Alessandro Piccolo
SWSheridan Woo
Sheridan Woo
Trichoderma are ubiquitous soil fungi that include species widely used as biocontrol agents in agriculture. Many isolates are known to secrete several secondary metabolites with different biological activities towards plants and other microbes. Harzianic acid (HA) is a T. harzianum metabolite able to promote plant growth and strongly bind iron. In this work, we isolated from the culture filtrate of a T. harzianum strain a new metabolite, named isoharzianic acid (iso-HA), a stereoisomer of HA. The structure and absolute configuration of this compound has been determined by spectroscopic methods, including UV-Vis, MS, 1D and 2D NMR analyses. In vitro applications of iso-HA inhibited the mycelium radial growth of Sclerotinia sclerotiorum and Rhizoctonia solani. Moreover, iso HA improved the germination of tomato seeds and induced disease resistance. HPLC-DAD experiments showed that the production of HA and iso HA was affected by the presence of plant tissue in the liquid medium. In particular, tomato tissue elicited the production of HA but negatively modulated the biosynthesis of its analogue iso-HA, suggesting that different forms of the same Trichoderma secondary metabolite have specific roles in the molecular mechanism regulating the Trichoderma plant interaction.

1 June 2018 in Seminars in Cell & Developmental Biology
Verified
Journal Article
Closed access
MMMargot De Marco
Margot De Marco
ABAnna Basile
Anna Basile
VIVittoria Iorio
Vittoria Iorio
MFMichelina Festa
Michelina Festa
AFAntonia Falco
Antonia Falco
Alessandra RosatiAlessandra Rosati
Alessandra Rosati

25 February 2019 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
Angelo SilverioAngelo Silverio
Angelo Silverio
Pierpaolo CavalloPierpaolo Cavallo
Pierpaolo Cavallo
RRRoberta De Rosa
Roberta De Rosa
Gennaro GalassoGennaro Galasso
Gennaro Galasso
Cardiovascular disease (CVD) accounts for the majority of death and hospitalization, health care expenditures and loss of productivity in developed country. CVD research, thus, plays a key role for improving patients' outcomes as well as for the sustainability of health systems. The increasing costs and complexity of modern medicine along with the fragmentation in healthcare organizations interfere with improving quality care and represent a missed opportunity for research. The advancement in diagnosis, therapy and prognostic evaluation of patients with CVD, indeed, is frustrated by limited data access to selected small patient populations, not standardized nor computable definition of disease and lack of approved relevant patient-centered outcomes. These critical issues results in a deep mismatch between randomized controlled trials and real-world setting, heterogeneity in treatment response and wide inter-individual variation in prognosis. Big data approach combines millions of people's electronic health records (EHR) from different resources and provides a new methodology expanding data collection in three direction: high volume, wide variety and extreme acquisition speed. Large population studies based on EHR holds much promise due to low costs, diminished study participant burden, and reduced selection bias, thus offering an alternative to traditional ascertainment through biomedical screening and tracing processes. By merging and harmonizing large data sets, the researchers aspire to build algorithms that allow targeted and personalized CVD treatments. In current paper, we provide a critical review of big health data for cardiovascular research, focusing on the opportunities of this largely free data analytics and the challenges in its realization.

26 January 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
Jacopo TroisiJacopo Troisi
Jacopo Troisi
FBFederica Belmonte
Federica Belmonte
ABAntonella Bisogno
Antonella Bisogno
Luca PierriLuca Pierri
Luca Pierri
ACAngelo Colucci
Angelo Colucci
Pietro VajroPietro Vajro
Pietro Vajro
Pediatric obesity-related metabolic syndrome (MetS) and nonalcoholic fatty liver disease (NAFLD) are increasingly frequent conditions with a still-elusive diagnosis and low-efficacy treatment and monitoring options. In this study, we investigated the salivary metabolomic signature, which has been uncharacterized to date. In this pilot-nested case-control study over a transversal design, 41 subjects (23 obese patients and 18 normal weight (NW) healthy controls), characterized based on medical history, clinical, anthropometric, and laboratory data, were recruited. Liver involvement, defined according to ultrasonographic liver brightness, allowed for the allocation of the patients into four groups: obese with hepatic steatosis ([St+], n = 15) and without hepatic steatosis ([St–], n = 8), and with (n = 10) and without (n = 13) MetS. A partial least squares discriminant analysis (PLS-DA) model was devised to classify the patients’ classes based on their salivary metabolomic signature. Pediatric obesity and its related liver disease and metabolic syndrome appear to have distinct salivary metabolomic signatures. The difference is notable in metabolites involved in energy, amino and organic acid metabolism, as well as in intestinal bacteria metabolism, possibly reflecting diet, fatty acid synthase pathways, and the strict interaction between microbiota and intestinal mucins. This information expands the current understanding of NAFLD pathogenesis, potentially translating into better targeted monitoring and/or treatment strategies in the future.

28 June 2016 in Pediatric Obesity
Verified
Journal Article
Closed access
PDF file
SNS. Guercio Nuzio
S. Guercio Nuzio
MSM. Di Stasi
M. Di Stasi
LPL. Pierri
L. Pierri
Jacopo TroisiJacopo Troisi
Jacopo Troisi
MPMarco Poeta
Marco Poeta
Pietro VajroPietro Vajro
Pietro Vajro